Popular New
- Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatment67 daysHemminki, A(kseli)*Read
- Familial Risks for Liver, Gallbladder and Bile Duct Cancers and for Their Risk Factors in Sweden, a Low-Incidence Country71 daysHemminki, A(kseli)*Read
- Long-term incidence in hepatocellular carcinoma and intrahepatic bile duct cancer in Denmark, Finland, Norway and Sweden, role of Thorotrast?78 daysHemminki, A(kseli)*Read
- Adenovirus Encoding Tumor Necrosis Factor Alpha and Interleukin 2 Induces a Tertiary Lymphoid Structure Signature in Immune Checkpoint Inhibitor Refractory Head and Neck Cancer94 daysHemminki, A(kseli)*Read
- Long-term incidence and survival trends in cancer of the gallbladder and extrahepatic bile ducts in Denmark, Finland, Norway and Sweden with etiological implications related to Thorotrast128 daysHemminki, A(kseli)*Read
- Oncolytic adenovirus decreases the proportion of TIM-3<sup>+</sup> subset of tumor-infiltrating CD8<sup>+</sup> T cells with correlation to improved survival in patients with cancer130 daysHemminki, A(kseli)*Read
- Local therapy with an engineered oncolytic adenovirus enables antitumor response in non-injected melanoma tumors in mice treated with aPD-1157 daysHemminki, A(kseli)*Read
- Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years180 daysHemminki, A(kseli)*Read
- Incidence, mortality and survival in malignant pleural mesothelioma before and after asbestos in Denmark, Finland, Norway and Sweden236 daysHemminki, A(kseli)*Read
- Types of second primary cancer influence overall survival in cutaneous melanoma257 daysHemminki, A(kseli)*Read
- Familial Risks and Proportions Describing Population Landscape of Familial Cancer296 daysHemminki, A(kseli)*Read
- Second Primary Cancers After Liver, Gallbladder and Bile Duct Cancers, and These Cancers as Second Primary Cancers326 daysHemminki, A(kseli)*Read
- Adenoviral CD40 Ligand Immunotherapy in 32 Canine Malignant Melanomas-Long-Term Follow Up328 daysHemminki, A(kseli)*Read
- Adenovirus Armed With TNFa and IL2 Added to aPD-1 Regimen Mediates Antitumor Efficacy in Tumors Refractory to aPD-1328 daysHemminki, A(kseli)*Read
- Treatment of Advanced Renal Cell Carcinoma: Immunotherapies Have Demonstrated Overall Survival Benefits While Targeted Therapies Have Not335 daysHemminki, A(kseli)*Read
- Survival in colon and rectal cancers in Finland and Sweden through 50 years350 daysHemminki, A(kseli)*Read
- Second Primary Cancers After Gastric Cancer, and Gastric Cancer as Second Primary Cancer359 daysHemminki, A(kseli)*Read
- Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden376 daysHemminki, A(kseli)*Read
- Oncolytic Adenovirus Coding for a Variant Interleukin 2 (vIL-2) Cytokine Re-Programs the Tumor Microenvironment and Confers Enhanced Tumor Control394 daysHemminki, A(kseli)*Read
- Incidence trends in lung and bladder cancers in the Nordic Countries before and after the smoking epidemic396 daysHemminki, A(kseli)*Read
- Incidence trends in bladder and lung cancers between Denmark, Finland and Sweden may implicate oral tobacco (snuff/snus) as a possible risk factor403 daysHemminki, A(kseli)*Read
- Systemic Delivery of Oncolytic Adenovirus to Tumors Using Tumor-Infiltrating Lymphocytes as Carriers429 daysHemminki, A(kseli)*Read
- Cytokine-Coding Oncolytic Adenovirus TILT-123 Is Safe, Selective, and Effective as a Single Agent and in Combination with Immune Checkpoint Inhibitor Anti-PD-1432 daysHemminki, A(kseli)*Read
- Oncolytic Adenovirus ORCA-010 Activates Proinflammatory Myeloid Cells and Facilitates T Cell Recruitment and Activation by PD-1 Blockade in Melanoma432 daysHemminki, A(kseli)*Read
- Oncolytic Adenovirus Type 3 Coding for CD40L Facilitates Dendritic Cell Therapy of Prostate Cancer in Humanized Mice and Patient Samples432 daysHemminki, A(kseli)*Read
- Cancer Predisposition Genes in Cancer-Free Families432 daysHemminki, A(kseli)*Read
- Rate differences between first and second primary cancers may outline immune dysfunction as a key risk factor432 daysHemminki, A(kseli)*Read
- Tumor microenvironment remodeling by an engineered oncolytic adenovirus results in improved outcome from PD-L1 inhibition432 daysHemminki, A(kseli)*Read
- Ad5/3 is able to avoid neutralization by binding to erythrocytes and lymphocytes432 daysHemminki, A(kseli)*Read
- Incidence Differences Between First Primary Cancers and Second Primary Cancers Following Skin Squamous Cell Carcinoma as Etiological Clues432 daysHemminki, A(kseli)*Read
- Informing patients about their mutation tests: CDKN2A c.256G>A in melanoma as an example432 daysHemminki, A(kseli)*Read
- Oncolytic viruses for cancer immunotherapy432 daysHemminki, A(kseli)*Read
- Comparison of Clinically Relevant Oncolytic Virus Platforms for Enhancing T Cell Therapy of Solid Tumors432 daysHemminki, A(kseli)*Read
- TNFa and IL2 Encoding Oncolytic Adenovirus Activates Pathogen and Danger-Associated Immunological Signaling432 daysHemminki, A(kseli)*Read
- Consensus guidelines for the definition, detection and interpretation of immunogenic cell death432 daysHemminki, A(kseli)*Read
- Second Primary Cancers in Melanoma Patients Critically Shorten Survival432 daysHemminki, A(kseli)*Read
- Modulation of the tumor microenvironment with an oncolytic adenovirus for effective T-cell therapy and checkpoint inhibition432 daysHemminki, A(kseli)*Read
- Association between tumor characteristics and second primary cancers with cutaneous melanoma survival: A nationwide cohort study432 daysHemminki, A(kseli)*Read
- Oncolytic adenovirus shapes the ovarian tumor microenvironment for potent tumor-infiltrating lymphocyte tumor reactivity432 daysHemminki, A(kseli)*Read
- Influence of family history on risk of second primary cancers and survival in patients with squamous cell skin cancer432 daysHemminki, A(kseli)*Read
- Constitutively active GSK3β as a means to bolster dendritic cell functionality in the face of tumour-mediated immune suppression432 daysHemminki, A(kseli)*Read
- Randomised Trial of Adjuvant Radiotherapy Following Radical Prostatectomy Versus Radical Prostatectomy Alone in Prostate Cancer Patients with Positive Margins or Extracapsular Extension432 daysHemminki, A(kseli)*Read
- Familial Risks and Mortality in Second Primary Cancers in Melanoma432 daysHemminki, A(kseli)*Read
- Second Primary Cancers in Patients with Invasive and In Situ Squamous Cell Skin Carcinoma, Kaposi Sarcoma, and Merkel Cell Carcinoma: Role for Immune Mechanisms?432 daysHemminki, A(kseli)*Read
- Second primary cancers in non-Hodgkin lymphoma: Family history and survival432 daysHemminki, A(kseli)*Read
- Types of second primary cancers influence survival in chronic lymphocytic and hairy cell leukemia patients432 daysHemminki, A(kseli)*Read
- Oncolytic adenoviruses: a game changer approach in the battle between cancer and the immune system432 daysHemminki, A(kseli)*Read
- Second primary cancers in patients with acute lymphoblastic, chronic lymphocytic and hairy cell leukaemia432 daysHemminki, A(kseli)*Read
- Effect of Genetic Modifications on Physical and Functional Titers of Adenoviral Cancer Gene Therapy Constructs432 daysHemminki, A(kseli)*Read
- Familial Associations of Colon and Rectal Cancers With Other Cancers432 daysHemminki, A(kseli)*Read

Impact Factor: 4.574
SJR: 1.897
JUFO: 0.933
Articles: 17
Terkko Factor: 48.4 (√IF*SJR*JUFO * Num)
Based on articles published in the last 12 months.
Profile on PlumX
- Medicine - All Feeds
- Allergology and Immunology
- Anatomy and Physiology
- Anesthesiology and Intensive Care
- Biochemistry
- Bioengineering
- Biophysics
- Biotechnology
- Cardiology
- Cardiothoracic Surgery
- Clinical Chemistry
- Clinical Medicine
- Complementary Medicine
- Cytology and Histology
- Dentistry
- Dermatology
- Endocrinology
- Forensic Medicine
- Gastroenterology
- General Practice
- Genetics
- Geriatrics
- Health services and Administration
- Hematology
- Infectious Diseases
- Internal Medicine
- Logopedics
- Medical Education and Humanities
- Medical Microbiology
- Medicine - Other
- Nephrology
- Neurology
- Neurosurgery
- Nursing
- Nutritional Sciences
- Obstetrics and Gynecology
- Occupational Health
- Oncology
- Ophthalmology
- Oral and Maxillofacial Surgery
- Orthopedics and Traumatology
- Otorhinolaryngology and Phoniatrics
- Pathology
- Pediatrics
- Pharmacology and Pharmacotherapy
- Physical and Rehabilitation Medicine
- Plastic Surgery
- Psychiatry
- Psychology
- Public Health
- Radiology
- Respiratory Medicine
- Rheumatology
- Sports Medicine
- Surgery
- Urology